During fatty liver development, pathological accumulation of diacylglycerol stimulates the activation of PKCε by enhancing its translocation to the plasma membrane, thereby impairing canonical insulin signaling that in turn leads to hepatic insulin resistance (11). The gene discussed is INS; the disease is Insulin resistance.